
Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial
Actinogen Medical Limited
Real estate transaction
Actinogen Medical Limited
State Grid Dezhou Power Supply Company
China Institute for Innovation & Development Strategy